ダウンロード数: 317

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
31_2090.pdf2.05 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.author熊本, 悦明ja
dc.contributor.author酒井, 茂ja
dc.contributor.author玉手, 広時ja
dc.contributor.author郷路, 勉ja
dc.contributor.author猪野毛, 健男ja
dc.contributor.author田端, 重男ja
dc.contributor.author丹田, 均ja
dc.contributor.author加藤, 修爾ja
dc.contributor.author井川, 欣市ja
dc.contributor.author田付, 二郎ja
dc.contributor.author辺見, 泉ja
dc.contributor.author生垣, 舜二ja
dc.contributor.author吉尾, 弘ja
dc.contributor.author上野, 了ja
dc.contributor.author出口, 浩一ja
dc.contributor.alternativeKUMAMOTO, Yoshiakien
dc.contributor.alternativeSAKAI, Shigeruen
dc.contributor.alternativeTAMATE, Hirotokien
dc.contributor.alternativeGOHRO, Tsutomuen
dc.contributor.alternativeINOKE, Takeoen
dc.contributor.alternativeTABATA, Shigeoen
dc.contributor.alternativeTANDA, Hitoshien
dc.contributor.alternativeKATO, Shujien
dc.contributor.alternativeIGAWA, Kinichien
dc.contributor.alternativeTAZUKI, Jiroen
dc.contributor.alternativeHENMI, Izumien
dc.contributor.alternativeIKEGAKI, Shunjien
dc.contributor.alternativeYOSHIO, Hiroshien
dc.contributor.alternativeUENO, Tooruen
dc.contributor.alternativeDEGUCHI, Kohichien
dc.date.accessioned2010-06-02T02:05:11Z-
dc.date.available2010-06-02T02:05:11Z-
dc.date.issued1985-11-
dc.identifier.issn0018-1994-
dc.identifier.urihttp://hdl.handle.net/2433/118646-
dc.description.abstract淋菌性感染症244例(男子尿道炎212例, 女子子宮頸管炎32例)に対し, Aztreonam one shot (1~2 g)治療を試みた.1)症例より分離した淋菌244株中42株(17.2%)がPPNGであった.2) Aztreonamの淋菌に対する106 CFU/mlでのMICはβ-lactamase産生に関係なく, 0.025 μg/mlにpeakをもち, 0.0125 μg/ml以下から0.2 μg/mlに分布していた.3) Aztreonam 1 gおよび2 g投与による淋菌の消失時間は1~8時間, 平均4~4.5時間の間に消失をみており, 1 gと2 gの間にほとんど差は認められなかった.4) Aztreonam 1 g one shot, 2 g one shotによる臨床効果を男女244例について検討したが, 3日所見で判定するとPPNGでも治療効果は変らず, 有効率は男子尿道炎では1 g 90.7%, 2 g 97.1%, 女子子宮頸管炎では1 g, 2 gとも100%であった.5) Aztreonamの副作用は244例中しびれ, 両手に発赤, 腫脹1例, 倦怠感1例の計2例(0.8%)にみられたがいずれも軽度であったja
dc.description.abstractA clinical study of a new monocyclic beta-lactam antibiotic, AZTREONAM (hereafter referred to as AZT) for gonorrheal infections as well as epidemiologic study of gonorrheal infections were made Epidemiology: There was a reflection of the increasing sexual activity of the younger generation; both male and female patients in their twenties were most frequent (male 49.5%, female 43.7%) and the percent of teen age patients was 15.1% (male) and 34.4% (female). Forty two strains (17.2%) out of 244 clinically isolated gonococci were PPNG. Residue of serious secretion was observed in a little less than 20% suggesting a complication by Chlamydia trachomatis. Clinical Result: One shot (1-2 g) therapy by AZT was given to 244 gonorrheal infection cases (212 urethritis cases of males. 32 cervicitis cases of females) with the following highly effective rate. Although beta-lactamase producing MIC of AZT at 10(6) CFU/ml showed a peak of 0.025 microgram/ml and ranged between less than 0.0125 microgram/ml to 0.2 microgram/ml. The time required for the elimination of gonococci was studied by the administration of 1 g and 2 g AZT. Gonococci became extinct in 1-8 hours or 4-4.5 hours on average. The difference between n 1 g and 2 g was scarcely observed. Clinical effect of 1 g one shot and 2 g one shot AZT was examined on the 3rd treatment day for 244 male and females cases. The effective rate was high; 90.7% by 1 g, 97.1% by 2 g for male urethritis, 100% by 1 g also by 2 g for female cervicitis. This therapeutic efficacy was kept even in PPNG, isolated cases. There were two side effects (0.8%), one case each of numbness and, redness and swelling of both hands, out of 244 cases, but both of them were minor ones without clinical complication.en
dc.format.mimetypeapplication/pdf-
dc.language.isojpn-
dc.publisher泌尿器科紀要刊行会ja
dc.subjectSTDen
dc.subjectGonorrheal infectionsen
dc.subjectAztreonamen
dc.subjectOne shot therapyen
dc.subject.ndc494.9-
dc.title淋菌性感染症の疫学的治療学的研究 --Aztreonamによるone shot療法の検討--ja
dc.title.alternativeEpidemiologic and therapeutic study on gonorrheal infections--one shot therapy by aztreonamen
dc.typedepartmental bulletin paper-
dc.type.niitypeDepartmental Bulletin Paper-
dc.identifier.ncidAN00208315-
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume31-
dc.identifier.issue11-
dc.identifier.spage2090-
dc.identifier.epage2104-
dc.textversionpublisher-
dc.sortkey27-
dc.address札幌医科大学泌尿器科学教室ja
dc.address札幌医科大学泌尿器科学教室ja
dc.address玉手皮膚泌尿器科医院ja
dc.address札幌泌尿器科医院ja
dc.addressいのけ医院皮膚泌尿器科ja
dc.address田端皮膚泌尿器科医院ja
dc.address東札幌三樹会病院泌尿器科ja
dc.address東札幌三樹会病院泌尿器科ja
dc.address陸上自衛隊札幌地区病院泌尿器科ja
dc.address陸上自衛隊札幌地区病院泌尿器科ja
dc.address辺見医院皮膚泌尿器科ja
dc.addressいけがき皮膚泌尿器科医院ja
dc.address吉尾病院産婦人科ja
dc.address第一臨床検査センターja
dc.address東京総合臨床検査センターja
dc.address.alternativethe Depatment of Urology, Sapporo Medical Collegeen
dc.address.alternativethe Tamate Clinicen
dc.address.alternativethe Sapporo Urology Clinicen
dc.address.alternativethe Inoke Clinicen
dc.address.alternativethe Tabata Clinicen
dc.address.alternativethe Higashi Sapporo Sanjukai Hospitalen
dc.address.alternativethe Higashi Sapporo Sanjukai Hospitalen
dc.address.alternativethe Depatment of Urology, Self- Defens Feorce Sapporo Hospitalen
dc.address.alternativethe Depatment of Urology, Self- Defens Feorce Sapporo Hospitalen
dc.address.alternativethe Henmi Clinicen
dc.address.alternativethe Ikegaki Clinicen
dc.address.alternativethe Yoshio Clinicen
dc.address.alternativethe Daiichi Clinical Research Centeren
dc.address.alternativethe Tokyo Clinical Research Centeren
dc.identifier.pmid3937450-
dcterms.accessRightsopen access-
dc.identifier.pissn0018-1994-
dc.identifier.jtitle-alternativeActa urologica Japonicala
dc.identifier.jtitle-alternativeHinyokika Kiyoen
出現コレクション:Vol.31 No.11

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。